Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
Replication-associated base excision repair/single-strand break repair regulates PARG inhibitor response via the PRMT1/PRMT5/ATR axis. [PDF]
Ibrahim M +14 more
europepmc +1 more source
Intrinsic PARG inhibitor sensitivity is mimicked by TIMELESS haploinsufficiency and rescued by nucleoside supplementation. [PDF]
Coulson-Gilmer C +16 more
europepmc +1 more source
Homogeneous Time-Resolved Fluorescence-Based Assay to Screen ADP-Ribosyl Hydrolase Inhibitors. [PDF]
Yu A, Wu D.
europepmc +1 more source
PARG Governs a PARylation-Ubiquitination Toggle that Stabilizes RAD51AP1 to Drive Homologous Recombination-Mediated Chemoresistance. [PDF]
He H +24 more
europepmc +1 more source
FET proteins and PARylation-dependent condensates promote replication fork reversal and genome stability. [PDF]
Giansanti C +4 more
europepmc +1 more source
Overcoming Resistance to PARP Inhibitors in BRCA-Mutated Cancers: Mechanisms and Therapeutic Strategies. [PDF]
Guo J, Wang Y, Li J, Jiang Z.
europepmc +1 more source
PARG inhibition in ATM-deficient prostate cancer: from mechanistic discovery to therapeutic potential. [PDF]
Zhou X +7 more
europepmc +1 more source
Delaying Stress Granule Disassembly by PARG Inhibition Attenuates Renal Tubular Cell Pyroptosis in Acute Kidney Injury. [PDF]
Song Y +5 more
europepmc +1 more source
CHD1L maintains genome integrity by facilitating okazaki fragment maturation. [PDF]
Nie L +8 more
europepmc +1 more source

